ITN1969
ITN1969
ITN1969
from
$424.00
Price in reward points: 424
- Catalog: ITN1969
- Gene/Protein: BCHE CHE1
- Product Description: Immunotag™ CHLE Polyclonal Antibody
-
Description
-
Specifications
Antibody Specification Datasheet 
IMPORTANT NOTE This product is custom manufactured with a lead time of 3-4 weeks. Once in production, this item cannot be cancelled from an order and is not eligible for return. Target Protein CHLE Clonality Polyclonal Storage/Stability -20°C/1 year Application WB,ELISA Recommended Dilution WB 1:500-2000 ELISA 1:5000-20000 Concentration 1 mg/ml Reactive Species Human Host Species Rabbit Immunogen Synthesized peptide derived from part region of human protein Specificity CHLE Polyclonal Antibody detects endogenous levels of protein. Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen Form Liquid in PBS containing 50% glycerol, and 0.02% sodium azide. Gene Name BCHE CHE1 Accession No. P06276 Q03311 Description butyrylcholinesterase(BCHE) Homo sapiens This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016], Protein Expression Brain,Fetus,Liver,Plasma,Skin,Stomach, Subcellular Localization extracellular region,nuclear envelope lumen,endoplasmic reticulum lumen,membrane,integral component of membrane,blood microparticle, Protein Function catalytic activity:An acylcholine + H(2)O = choline + a carboxylate.,disease:Defects in BCHE are the cause of butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400]. BChE deficiency is a metabolic disorder characterized by prolonged apnoea after the use of certain anesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency. BChE deficiency is a multifactorial disorder. The hereditary condition is transmitted as an autosomal recessive trait.,miscellaneous:Cholinesterase is highly reactive with organophosphate esters.,similarity:Belongs to the type-B carboxylesterase/lipase family.,subunit:Homotetramer. The tetramer is composed of two dimers. The two subunits in a dimer are linked by a disulfide bond.,tissue specificity:Present in most cells except erythrocytes., Usage For Research Use Only! Not for diagnostic or therapeutic procedures. - Reviews
| Antibody Specification | |
| Datasheet | |
| IMPORTANT NOTE | This product is custom manufactured with a lead time of 3-4 weeks. Once in production, this item cannot be cancelled from an order and is not eligible for return. |
| Target Protein | CHLE |
| Clonality | Polyclonal |
| Storage/Stability | -20°C/1 year |
| Application | WB,ELISA |
| Recommended Dilution | WB 1:500-2000 ELISA 1:5000-20000 |
| Concentration | 1 mg/ml |
| Reactive Species | Human |
| Host Species | Rabbit |
| Immunogen | Synthesized peptide derived from part region of human protein |
| Specificity | CHLE Polyclonal Antibody detects endogenous levels of protein. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen |
| Form | Liquid in PBS containing 50% glycerol, and 0.02% sodium azide. |
| Gene Name | BCHE CHE1 |
| Accession No. | P06276 Q03311 |
| Description | butyrylcholinesterase(BCHE) Homo sapiens This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016], |
| Protein Expression | Brain,Fetus,Liver,Plasma,Skin,Stomach, |
| Subcellular Localization | extracellular region,nuclear envelope lumen,endoplasmic reticulum lumen,membrane,integral component of membrane,blood microparticle, |
| Protein Function | catalytic activity:An acylcholine + H(2)O = choline + a carboxylate.,disease:Defects in BCHE are the cause of butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400]. BChE deficiency is a metabolic disorder characterized by prolonged apnoea after the use of certain anesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency. BChE deficiency is a multifactorial disorder. The hereditary condition is transmitted as an autosomal recessive trait.,miscellaneous:Cholinesterase is highly reactive with organophosphate esters.,similarity:Belongs to the type-B carboxylesterase/lipase family.,subunit:Homotetramer. The tetramer is composed of two dimers. The two subunits in a dimer are linked by a disulfide bond.,tissue specificity:Present in most cells except erythrocytes., |
| Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |